Trump Set to Reschedule Cannabis Today in Historic Policy Shift

Editor's Brief

Today may be the most consequential day in American cannabis policy since the plant was criminalized decades ago. Multiple major outlets — Bloomberg, Reuters, the Washington Post, and MJBizDaily — are reporting that the Trump administration is prepared to move cannabis from Schedule I to Schedule III as soon as today. Markets are already reacting, pot stocks are surging, and the industry is holding its collective breath.

But make no mistake: rescheduling is not legalization. While the policy shift carries enormous practical and symbolic weight, it leaves state-legal markets still operating in a complex federal gray zone. Meanwhile, Virginia's governor faces a showdown over recreational sales, California is eyeing drive-thru dispensaries, and Minnesota's teen use data delivers a win for legalization advocates.

It's a big news day. Let's break it all down.

Top Story

Cannabis Rescheduling Is Finally Happening — Here's What It Actually Means

After more than four months since President Trump signed an executive order directing the attorney general to expedite the process, the administration is reportedly ready to formally move cannabis from Schedule I to Schedule III of the Controlled Substances Act. Bloomberg, Reuters, the Washington Post, and MJBizDaily all confirmed the move is imminent — possibly effective today, April 23, 2026.

This is genuinely historic. Schedule I classification has defined cannabis policy — and crippled cannabis research — for over 50 years. Moving to Schedule III acknowledges, for the first time at the federal level, that cannabis has accepted medical use and lower potential for abuse than heroin or LSD. That single acknowledgment reshapes the entire legal and scientific landscape.

For the industry, the most immediate impact is the long-awaited relief from IRS Section 280E, the tax provision that has prevented cannabis businesses from deducting normal operating expenses. Rescheduling removes that burden, potentially making hundreds of legal cannabis companies profitable overnight. Cannabis stocks reflected this hope immediately — Canopy Growth and Tilray both surged on the news.

For consumers and growers, however, the day-to-day reality changes less dramatically. Cannabis remains illegal under federal law for recreational use. State-licensed dispensaries still operate under state law. Home cultivation rules don't change federally. What changes is the trajectory — rescheduling is the clearest signal yet that full federal legalization is a matter of when, not if. Watch for formal DEA and DOJ announcements in the coming hours and days.

Policy & Legalization

Virginia Governor Faces Showdown Over Rec Sales

Virginia lawmakers voted to reject Governor Abigail Spanberger's amendments to the state's recreational marijuana sales legalization bill. The House of Delegates declined — in a voice vote — to adopt her proposed changes, sending the original proposal back to her desk. A veto now looms as the most likely outcome, potentially delaying adult-use sales in the state.

California Eyes Drive-Thru Dispensaries

A California bill that would allow licensed cannabis retailers and microbusinesses to offer drive-thru windows cleared the Assembly Business and Professions Committee in a 17-2 landslide vote. The model draws inspiration from how some markets — including New Orleans — have approached cannabis retail access. Faster, more convenient purchasing could expand the legal market's reach against illicit competition.

Clovis, New Mexico Holds Legalization Education Sessions

Educational sessions on cannabis legalization are scheduled for Thursday in Clovis, as communities across the country continue working through what state and potential federal policy changes mean locally. Grassroots education efforts like these are often the front line of normalization — especially in regions where legalization remains politically sensitive.

Business & Markets

Pot Stocks Pop on Rescheduling News

Cannabis equities surged Wednesday as rescheduling reports hit the wire. Canopy Growth and Tilray both posted significant gains, reflecting investor confidence that Schedule III status will unlock 280E tax relief and attract institutional capital that has been sitting on the sidelines. The Tilray CEO appeared on Bloomberg to discuss what reclassification could mean for the company's U.S. strategy.

Iowa Democrat Proposes Adult-Use Legalization to Close Budget Gap

Iowa state auditor and Democratic gubernatorial candidate Rob Sand released a formal adult-use cannabis legalization plan, framing it explicitly as a fiscal solution to the state's nearly $1.4 billion budget shortfall. "Iowans are driving across state lines" to buy cannabis legally elsewhere, Sand noted — a familiar argument that is gaining traction in even traditionally conservative states.

Minnesota Teen Use Drops Sharply Since 2013

New data from the 2025 Minnesota Student Survey shows cannabis use among 11th graders nearly halved from 25.2% in 2013 to 12.7% in 2025. Use among 9th graders also fell significantly. The findings directly counter the argument that legalization increases youth access — and hand advocates a powerful data point as federal rescheduling debates heat up.

Science & Cultivation

Higher Education Marijuana Research Act Would Unlock Academic Study

A new federal bill introduced by co-chairs of the Congressional Cannabis Caucus would create formal protections for academics and universities conducting cannabis research and remove existing barriers to scientific study. Introduced on April 20 — naturally — the Higher Education Marijuana Research Act arrives just as rescheduling itself is expected to ease some federal research restrictions. Together, these moves could trigger a long-overdue wave of peer-reviewed cannabis science.

For growers, more open research means better data on cannabinoid profiles, terpene expression, cultivation optimization, and plant health. The decades-long research drought caused by Schedule I status has left cultivators relying heavily on anecdotal knowledge. That era may finally be ending.

Caffeine and Cannabis: A Growing Conversation

Consumer interest in combining caffeine and cannabis — through infused beverages, morning routines, and microdosing habits — is rising alongside the broader wellness market. The interaction between caffeine's stimulant effects and cannabis's variable impact on focus and anxiety is nuanced and deserves more rigorous study. Home growers who consume their own product in the morning should pay attention as this research matures.

Culture & Community

High Times and Last Prisoner Project Launch Ongoing Partnership

High Times and the Last Prisoner Project announced an ongoing partnership to keep cannabis prisoners at the center of the legalization movement. As federal rescheduling dominates headlines, it's a timely reminder that thousands of Americans remain incarcerated for cannabis offenses that are now legal or soon may be. The collaboration will amplify prisoner stories and push for expungement alongside broader reform.

Spain Enters a More Volatile Phase of Cannabis Culture

High Times reports on Spain's evolving cannabis scene — from home grow labs and dangerous butane extraction to the rise of solventless rosin and ongoing police raids in a persistent legal gray zone. Spain's cannabis social clubs and DIY extract culture offer a fascinating window into what happens when demand outpaces legal frameworks. Sound familiar?

What This Means for Growers

• Rescheduling doesn't change your home grow rights today — but it signals a federal posture that is increasingly tolerant. Stay current with your state's laws; they remain the governing framework.
• Research access is about to expand dramatically. The combination of rescheduling and the Higher Education Marijuana Research Act means peer-reviewed data on cultivar performance, pest resistance, and cannabinoid production could finally start flowing freely.
• Legal market expansion is coming fast. California drive-thrus, Iowa legalization proposals, and Virginia's ongoing sales debate all point toward a broader, more competitive legal market — which could pressure pricing on flower and concentrates.
• Minnesota's youth use data matters to you. Every data point showing legalization doesn't increase teen use makes further state and federal reform more politically viable — which ultimately means more freedom for home cultivators.
• Watch 280E relief closely. If rescheduling removes the tax burden from legal cannabis businesses, it could reshape which companies survive, which products dominate shelves, and what genetics get commercial investment — all of which filters down to the home growing community through seed availability and strain trends.

Quick Links

Full source links are listed below this article.